SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 1 filers reported holding SYNTHETIC BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $65,000 | -11.0% | 303,152 | +17.7% | 0.00% | – |
| Q1 2022 | $73,000 | +23.7% | 257,590 | +19.2% | 0.00% | – |
| Q4 2021 | $59,000 | -37.2% | 216,089 | +6.1% | 0.00% | – |
| Q3 2021 | $94,000 | -8.7% | 203,643 | +18.9% | 0.00% | – |
| Q2 2021 | $103,000 | +114.6% | 171,301 | +142.0% | 0.00% | – |
| Q1 2021 | $48,000 | +128.6% | 70,793 | +29.8% | 0.00% | – |
| Q4 2020 | $21,000 | -16.0% | 54,537 | +3.2% | 0.00% | – |
| Q3 2020 | $25,000 | -19.4% | 52,862 | -13.3% | 0.00% | – |
| Q2 2020 | $31,000 | +72.2% | 60,994 | +11.7% | 0.00% | – |
| Q1 2020 | $18,000 | -30.8% | 54,612 | +6.5% | 0.00% | – |
| Q4 2019 | $26,000 | +8.3% | 51,264 | -3.2% | 0.00% | – |
| Q3 2019 | $24,000 | -20.0% | 52,955 | -2.0% | 0.00% | – |
| Q2 2019 | $30,000 | -21.1% | 54,048 | -4.4% | 0.00% | – |
| Q1 2019 | $38,000 | +52.0% | 56,564 | +27.0% | 0.00% | – |
| Q4 2018 | $25,000 | – | 44,554 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 903,741 | $497,000 | 0.62% |
| Alyeska Investment Group, L.P. | 5,000,000 | $2,750,000 | 0.04% |
| WEDBUSH SECURITIES INC | 97,957 | $54,000 | 0.01% |
| SCOPUS ASSET MANAGEMENT, L.P. | 225,000 | $124,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 60,000 | $33,000 | 0.00% |
| 683 Capital Management, LLC | 42,858 | $24,000 | 0.00% |
| UBS Group AG | 600 | $0 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1 | $1,000 | 0.00% |
| Advisor Group, Inc. | 421 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 316 | $0 | 0.00% |